Congratulations to KL2 Alumnus Michael Saltin, MD, for publishing a study in Cancer Cell entitled "SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer who are Hospitalized with COVID-19." Dr. Satlin and his team of researchers discovered that cancer patients "may be at increased risk of severe coronavirus disease 2019 (COVID-19), but the role of viral load on this risk is unknown." This led his team to the ultimate conclusion of SARS-CoV-2 viral load results having an impact on prognostic information for patients with cancer and without cancer being hospitalized due to COVID-19.

Dr. Satlin was appointed a KL2 Scholar in 2012, his research focused on "Epidemiology of Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies." Since then, Dr. Satlin has received the R01 Grant from the National institute of Allergy and Infectious Disease for his work with "Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neurotropenic Patients".  He currently works as an Associate Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine.

The CTSC KL2 Career Development Core Program supports junior faculty and senior residents and fellows by providing salary support, protected time, advanced degree training, and practical skills necessary to conduct interdisciplinary Clinical Translational Investigation within a team research environment.